| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| (R)-CPP |
DCPP |
126453-07-4 |
詳細(xì)
|
| (±)-Methoxyverapamil hydrochloride |
METHOXYVERAPAMIL HYDROCHLORIDE |
16662-46-7 |
詳細(xì)
|
| SB 223412 |
TALNETANT |
174636-32-9 |
詳細(xì)
|
| Xanthurenic acid |
4,8-二羥基喹啉-2-甲酸 |
59-00-7 |
詳細(xì)
|
| Amdinocillin |
美西林 |
32887-01-7 |
詳細(xì)
|
| YM 58483 |
YM-5883 |
223499-30-7 |
詳細(xì)
|
| KH 7 |
KH7 |
330676-02-3 |
詳細(xì)
|
| SMER 3 |
SMER 3 |
67200-34-4 |
詳細(xì)
|
| (±)-E-Homocamptothecin |
|
186668-40-6 |
詳細(xì)
|
| Izonsteride |
IZONSTERIDE |
176975-26-1 |
詳細(xì)
|
| Disopyramide phosphate |
磷酸丙吡胺 |
22059-60-5 |
詳細(xì)
|
| CID 1067700 |
2-[[(苯甲?；被?硫代甲酰]氨基]-4,7-二氫-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 |
314042-01-8 |
詳細(xì)
|
| MreB Perturbing Compound A22 |
AMINO[(3,4-DICHLOROBENZYL)SULFANYL]METHANIMINIUM CHLORIDE |
22816-60-0 |
詳細(xì)
|
| VU 0029767 |
化合物 T29120 |
326001-01-8 |
詳細(xì)
|
| GLP-1R agonist DMB |
Compound 2 |
281209-71-0 |
詳細(xì)
|
| (R)-6-Hydroxy-DPAT hydrobromide |
|
1246094-81-4 |
詳細(xì)
|
| FK 960 |
FK 960 |
133920-70-4 |
詳細(xì)
|
| GSK 461364 analogue II |
|
929095-22-7 |
詳細(xì)
|
| KY 05009 |
1228280-29-2 |
1228280-29-2 |
詳細(xì)
|
| PRMT3 inhibitor 1 |
|
1340875-03-7 |
詳細(xì)
|
| Sephin 1 |
化合物SEPHIN 1 |
951441-04-6 |
詳細(xì)
|
| BQR695 |
BQR695 |
1513879-21-4 |
詳細(xì)
|
| Enfuvirtide |
恩夫韋地 |
159519-65-0 |
詳細(xì)
|
| 1-Linoleoyl glycerol |
一亞油酸甘油酯 |
2277-28-3 |
詳細(xì)
|
| Lys-[Des-Arg9]Bradykinin |
賴氨酸-(脫-精氨酸9)舒愛激肽 |
71800-36-7 |
詳細(xì)
|
| Aspartic acid calcium |
L-天門冬氨酸鈣 |
21059-46-1 |
詳細(xì)
|
| Zotepine |
佐替平 |
26615-21-4 |
詳細(xì)
|
| Carcinine ditrifluoroacetate |
N-2-[(4-1H-咪唑基)乙基]-3-氨基丙酰胺二鹽酸鹽 |
56897-53-1 |
詳細(xì)
|
| Tacrine |
他克林 |
321-64-2 |
詳細(xì)
|
| (RS)-AMPA |
(±)-Α-氨基-3-羥基-5-甲基異惡唑-4-丙酸 |
74341-63-2 |
詳細(xì)
|
| SLIGKV-NH2 |
H-絲氨酰亮氨酰異亮氨酰甘氨酰賴氨酰纈氨酰NH2 |
190383-13-2 |
詳細(xì)
|
| LP 44 |
LP 44 |
824958-12-5 |
詳細(xì)
|
| SKF 86466 hydrochloride |
SKF 86466 HYDROCHLORIDE |
86129-54-6 |
詳細(xì)
|
| Chlorcyclizine hydrochloride (1:x) |
鹽酸氯環(huán)嗪 |
1620-21-9 |
詳細(xì)
|
| Glafenine hydrochloride |
格拉非寧 鹽酸鹽 |
65513-72-6 |
詳細(xì)
|
| Trimazosin hydrochloride |
TRIMAZOSIN HYDROCHLORIDE |
53746-46-6 |
詳細(xì)
|
| β-CCB |
N-丁基-Β-咔啉-3-羧酸酯 |
84454-35-3 |
詳細(xì)
|
| Spectinomycin |
大觀霉素 |
1695-77-8 |
詳細(xì)
|
| Gemopatrilat |
GEMOPATRILAT |
160135-92-2 |
詳細(xì)
|
| Antioxidant 330 |
抗氧劑 330 |
1709-70-2 |
詳細(xì)
|
| PPT |
PPT |
263717-53-9 |
詳細(xì)
|
| GMC 1-116 |
11-(4-甲基-1-哌嗪基) |
63687-94-5 |
詳細(xì)
|
| Novokinin |
Novokinin |
358738-77-9 |
詳細(xì)
|
| SF 11 |
N-(4-Ethoxyphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinecarbothioamide |
443292-81-7 |
詳細(xì)
|
| SR 144528 |
化合物 SR144528 |
192703-06-3 |
詳細(xì)
|
| LY 2886721 hydrochloride |
N-[3-[(4AS,7AS)-2-氨基-5,7-二氫-4H-呋喃并[3,4-D][1,3]噻嗪-7A(4AH)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺鹽酸鹽 |
1262036-49-6 |
詳細(xì)
|
| CP 226269 |
CP-226269 |
220941-93-5 |
詳細(xì)
|
| AS 1517499 |
AS1517499 |
919486-40-1 |
詳細(xì)
|
| WAY 161503 hydrochloride |
8,9-DICHLORO-2,3,4,4A-TETRAHYDRO-1H-PYRAZINO[1,2-A]QUINOXALIN-5(6H)-ONE HYDROCHL |
276695-22-8 |
詳細(xì)
|
| Remogliflozin |
329045-45-6 |
329045-45-6 |
詳細(xì)
|
| DIM-C-pPhOCH3 |
3,3'-((4-Methoxyphenyl)Methylene)bis(1H-indole) |
33985-68-1 |
詳細(xì)
|
| CP 93129 dihydrochloride |
CP-93129 Dihydrochloride Hydrate |
879089-64-2 |
詳細(xì)
|
| Cuspin-1 |
Cuspin-1 |
337932-29-3 |
詳細(xì)
|
| 3-[2-(Diproplyamino)ethyl]phenol hydrobromide |
|
64656-40-2 |
詳細(xì)
|
| CK2 inhibitor 10 |
CK2 inhibitor 10 |
1361229-76-6 |
詳細(xì)
|
| S 12 |
|
258264-62-9 |
詳細(xì)
|
| AX-024 hydrochloride |
AX-024 HYDROCHLORIDE |
1704801-24-0 |
詳細(xì)
|
| Ketanserin tartrate |
酒石酸酮色林 |
83846-83-7 |
詳細(xì)
|
| UBP 302 |
UBP302, PUBCHEM CID: 6420161 |
745055-91-8 |
詳細(xì)
|
| CCG 232601 |
CCG-232601 |
1922099-21-5 |
詳細(xì)
|
| MRS 1523 |
MRS 1523 |
212329-37-8 |
詳細(xì)
|
| TMPH hydrochloride |
TMPH HYDROCHLORIDE |
849461-91-2 |
詳細(xì)
|